TOMMASI, MARIASILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.158
EU - Europa 680
AS - Asia 113
AF - Africa 5
SA - Sud America 2
Totale 1.958
Nazione #
US - Stati Uniti d'America 1.155
SE - Svezia 178
IE - Irlanda 127
PL - Polonia 118
UA - Ucraina 70
HK - Hong Kong 62
DE - Germania 53
IT - Italia 48
FI - Finlandia 26
GB - Regno Unito 26
TR - Turchia 15
JO - Giordania 13
CN - Cina 12
AT - Austria 9
CH - Svizzera 9
BE - Belgio 6
FR - Francia 5
IN - India 4
RU - Federazione Russa 4
VN - Vietnam 4
CA - Canada 3
SC - Seychelles 3
SG - Singapore 3
CD - Congo 2
BR - Brasile 1
NL - Olanda 1
VE - Venezuela 1
Totale 1.958
Città #
Chandler 209
Dublin 127
Fairfield 127
Jacksonville 127
Warsaw 118
Ashburn 76
Woodbridge 62
Wilmington 60
Seattle 57
Cambridge 48
Houston 43
Ann Arbor 41
Hong Kong 38
Buffalo 28
Princeton 28
Boston 24
Boardman 21
Izmir 15
Altamura 11
Lawrence 11
Bern 9
Medford 9
Vienna 9
Beijing 7
Brussels 6
Florence 6
Norwalk 6
San Diego 5
Shanghai 5
Los Angeles 4
Milan 4
New York 4
Auburn Hills 3
Frankfurt Am Main 3
Pune 3
Singapore 3
Dong Ket 2
Laurel 2
Montichiari 2
Moscow 2
Andover 1
Arnsberg 1
Atlantic City 1
Boynton Beach 1
Brampton 1
Bremen 1
Chicago 1
Grafing 1
Hillsboro 1
Martellago 1
Miami Beach 1
Napoli 1
Ottawa 1
Paris 1
Philadelphia 1
Phoenix 1
Pisa 1
Rieti 1
Saint Petersburg 1
Salerno 1
Sava 1
Scarborough 1
São Paulo 1
Terni 1
Trumbull 1
Totale 1.390
Nome #
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 218
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma 89
Creatine Kinase isoenzyme BB : a lung cancer associated marker 88
A controversial problem: is there a relationship between parathyroid hormone level and parathyroid size in primary hyperparathyroidism? 86
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? 84
Intact PTH vs. the whole PTH assay in uremic samples 84
Prognostic significance of tissue polypeptide antigen (TPA) in head and neck carcinomas. 83
Serum Tissue Polypeptide Antigen (TPA): a marker of acute injury on salivary glands during radiation therapy. 81
Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. 80
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 76
The role of a new monoclonal antibody assay in the detection of recurrent breast cancer 76
Kinetics Analysis of Parathyroid Hormone During Parathyroidectomy in the Assessment of Curative Surgery 76
Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias 64
Primary Hyperparathyroidism: biochemical features and intraoperative monitoring of intact PTH during surgery 64
Effects of Melatonin administration on cytochine production in patients with advanced solid tumors 62
Beta2-microglobulina, marker tumorale nel mieloma multiplo 62
Primary Hyperparathyroidism: Biochemical Features and Intraoperative Monitoring of intact PTH during Surgery 59
COMPARAISON OF THE USEFULNESS OF DOPPLER-DERIVED DECELERATION TIME VERSUS PLASMA BRAIN NATRIURETIC PEPTIDE TO PREDICT LEFT VENTRICULAR REMODELING AFTER MECHANICAL REVASCULARIZATION IN PATIENTS WITH ST--ELEVATION ACUTE MYOCARDIAL INFARCTION AND LEFT VENTRICULAR SISTOLIC DYSFUNCTION 57
Assessment of Phosphohexose-isomerase, Beta2-microgubulin and Ferritin in lung cancer 55
CLINICAL UTILITY OF COMBINED USE OF PLURIME TUMOR MARKERS IN HUMAN BREAST CANCER 54
Tissue CEA concentration in colorectal carcinoma and in the proximal mucosa. 53
Effects of melatonin administration in patients with advanced solid tumors 50
Bio-markers in the detection of myeloproliferactive diseases : a combined study on Phosphohexose isomerase Beta2-microglobulin ad Ferritin 50
Evaluation of reference values for chromogranin A, pancreatic peptide and somatostatin 48
Esperienza preliminare del nuovo dosaggio "whole PTH" nel monitoraggio intraoperatorio per iperparatiroidismo primario 45
FERRITIN AS CHRONOBIOLOGICAL MARKER IN IMMUNOPROLIFERATIVE DISEASE 44
Model of iPTH clearance after parathyroid adenomectomy 39
Critical analysis of intact PTH monitoring during parathyroid surgery 36
Totale 1.963
Categoria #
all - tutte 5.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019131 0 0 0 0 0 0 0 0 0 27 62 42
2019/2020335 26 32 5 38 31 48 28 46 28 16 31 6
2020/2021306 24 11 33 34 6 43 10 28 23 40 16 38
2021/2022202 14 23 1 15 4 4 7 8 6 8 68 44
2022/2023609 51 91 39 68 50 106 66 55 60 3 9 11
2023/2024175 6 25 25 6 12 43 7 44 2 5 0 0
Totale 1.963